Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins
暂无分享,去创建一个
Z. Weng | B. Pierce | Jianhong Hu | Soo-Jin Han | R. Renne
[1] Jaap Heringa,et al. Protein secondary structure prediction. , 2010, Methods in molecular biology.
[2] S. Bouaziz,et al. Conserved domains and structure prediction of human cytomegalovirus UL27 protein , 2008, Antiviral therapy.
[3] S. Günther,et al. Mutational Evidence for a Structural Model of the Lassa Virus RNA Polymerase Domain and Identification of Two Residues, Gly1394 and Asp1395, That Are Critical for Transcription but Not Replication of the Genome , 2008, Journal of Virology.
[4] K. Gaston,et al. The papillomavirus E2 DNA binding domain. , 2008, Frontiers in bioscience : a journal and virtual library.
[5] Zhiping Weng,et al. ZRANK: Reranking protein docking predictions with an optimized energy function , 2007, Proteins.
[6] M. Ballestas,et al. Determination of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding , 2007, Journal of Virology.
[7] P. Lieberman,et al. Human Herpesviruses: Gammaherpesvirus maintenance and replication during latency , 2007 .
[8] S. Verma,et al. Structure and function of latency-associated nuclear antigen. , 2007, Current topics in microbiology and immunology.
[9] K. Burnside,et al. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells. , 2006, Virology.
[10] P. Howley,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes , 2006, Journal of Virology.
[11] S. Verma,et al. Latency-Associated Nuclear Antigen (LANA) of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Origin Recognition Complexes at the LANA Binding Sequence within the Terminal Repeats , 2006, Journal of Virology.
[12] K. Luger,et al. The Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA , 2006, Science.
[13] Angus C. Wilson,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces a Strong Bend on Binding to Terminal Repeat DNA , 2005, Journal of Virology.
[14] J. Bujnicki,et al. Sequence–structure–function relationships of a tRNA (m7G46) methyltransferase studied by homology modeling and site‐directed mutagenesis , 2005, Proteins.
[15] Zhiping Weng,et al. M-ZDOCK: a grid-based approach for Cn symmetric multimer docking , 2005, Bioinform..
[16] William Stedman,et al. ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin , 2004, Journal of Virology.
[17] D. Baker,et al. A simple physical model for the prediction and design of protein-DNA interactions. , 2004, Journal of molecular biology.
[18] András Fiser,et al. ModLoop: automated modeling of loops in protein structures , 2003, Bioinform..
[19] D. Ganem,et al. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing Plasmids , 2003, Journal of Virology.
[20] Jianhong Hu,et al. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells , 2002, Journal of Virology.
[21] C. Lim,et al. Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome , 2002, Journal of Virology.
[22] Jianhong Hu,et al. Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.
[23] T. Fujita,et al. Amino Acid Substitution Analyses of the DNA Contact Region, Two Amphipathic α-Helices and a Recognition-Helix-Like Helix outside the Dimeric β-Barrel of Epstein-Barr Virus Nuclear Antigen 1 , 2001, Intervirology.
[24] Jianhong Hu,et al. DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[25] E. Kremmer,et al. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein–Barr virus , 2001, The EMBO journal.
[26] M. Ballestas,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.
[27] P. Brown,et al. Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[28] M J Sternberg,et al. Enhancement of protein modeling by human intervention in applying the automatic programs 3D‐JIGSAW and 3D‐PSSM , 2001, Proteins.
[29] S. Mahajan,et al. Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies , 2000, Journal of Virology.
[30] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[31] Aled M. Edwards,et al. Two Domains of the Epstein-Barr Virus Origin DNA-binding Protein, EBNA1, Orchestrate Sequence-specific DNA Binding* , 2000, The Journal of Biological Chemistry.
[32] L. Frappier,et al. Functional Analyses of the EBNA1 Origin DNA Binding Protein of Epstein-Barr Virus , 2000, Journal of Virology.
[33] E. Robertson,et al. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.
[34] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[35] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[36] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[37] R. Pfuetzner,et al. Crystal Structure of the DNA-Binding Domain of the Epstein–Barr Virus Origin-Binding Protein, EBNA1, Bound to DNA , 1996, Cell.
[38] S. Grossman,et al. EBNA1 and E2: a new paradigm for origin-binding proteins? , 1996, Trends in microbiology.
[39] A. Petros,et al. Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. , 1996, Biochemistry.
[40] O. Hermine,et al. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. , 1996, The New England journal of medicine.
[41] R. Pfuetzner,et al. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1 , 1995, Cell.
[42] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[43] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[44] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[45] S. Grossman,et al. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DMA-binding domain bound to its DNA target , 1992, Nature.
[46] O. Elroy-Stein,et al. New mammalian expression vectors , 1990, Nature.
[47] O. Elroy-Stein,et al. Product review. New mammalian expression vectors. , 1990, Nature.
[48] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[49] B. Hirt. Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.
[50] V. Georgiev. Virology , 1955, Nature.